Vitaeris

Vitaeris is a biopharmaceutical company that researches, develops and commercializes novel therapeutics for the treatment of rheumatoid arthritis. Read more

Kevin Chow's photo - President & CEO of Vitaeris

President & CEO

Kevin Chow

CEO Approval Rating

87/100

Founded:

2016

Status:

PrivateSubsidiary of CSL Behring

VITAERIS TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Aurinia is a top competitor of Vitaeris. Aurinia was founded in 2013, and is headquartered in Victoria, British Columbia. Aurinia is in the Biotechnology industry. Aurinia generates $48M more revenue vs. Vitaeris.

Eupraxia Pharmaceuticals is seen as one of Vitaeris's top competitors. Eupraxia Pharmaceuticals is headquartered in Victoria, British Columbia, and was founded in 2012. Like Vitaeris, Eupraxia Pharmaceuticals also competes in the Pharmaceuticals field. Eupraxia Pharmaceuticals generates NaN% the revenue of Vitaeris.

WEX Pharmaceuticals, Inc. has been one of Vitaeris's top competitors. WEX Pharmaceuticals, Inc.'s headquarters is in Vancouver, British Columbia, and was founded in 1987. WEX Pharmaceuticals, Inc. is in the Biotechnology field. WEX Pharmaceuticals, Inc. generates 133% of Vitaeris's revenue.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 15 a good estimate for Vitaeris's Employee count?

Vitaeris Acquisitions

No recent acquisitions found related to Vitaeris

Vitaeris Funding History

Since Vitaeris was founded in 2016, it has participated in 1 round of funding. In total Vitaeris has raised $7.0M. Vitaeris' funding round was on Jun 2016 for a total of $7.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Seed
Jun 2016
$7M

HBM Healthcare Investments AG

Since Vitaeris was founded in 2016, it has participated in 1 round of funding. In total Vitaeris has raised $7.0M. Vitaeris' funding round was on Jun 2016 for a total of $7.0M

Vitaeris Investments

No recent investments found related to Vitaeris

Vitaeris News

December 6, 2017PIPELINEREVIEW

CSL and Vitaeris Announce Strategic Partnership with Option to Acquire

CSL Limited (ASX:CSL; USOTC:CSLLY) and Vitaeris Inc. (Vitaeris) today announced that they have entere... See more »
December 5, 20174-traders

CSL and HBM-Portfolio Company Vitaeris Announce Strategic Partnership with Option to Acquire

(4-traders.com) NOT FOR DISTRIBUTION IN THE USA, CANADA, JAPAN OR AUSTRALIA Media Release Zug, 5 Dece... See more »
June 7, 2016FinSMEs

Biopharma Company Vitaeris Raises US$7M in Seed Funding

Vitaeris Inc., a Vancouver, Canada-based...... See more »

Vitaeris Press Releases

Social Media

Vitaeris Headquarters

355 Burrard Street Suite 1500

Vancouver, British ColumbiaV6C 2G8

1-844-448-2580

Driving Directions »

Trending Companies

Vitaeris Summary

ABOUT

Overview

Vitaeris is a biopharmaceutical company that researches, develops and commercializes novel therapeutics for the treatment of rheumatoid arthritis. Vitaeris was founded in 2016. Vitaeris' headquarters is located in Vancouver, British Columbia, CA V6C 2...

CEO

Vitaeris's President & CEO, Kevin Chow, currently has an approval rating of 87%. Vitaeris's primary competitors are Aurinia, Eupraxia Pharmaceuticals & WEX Pharmaceuticals, Inc..

Frequently Asked Questions about Vitaeris

  1. When was Vitaeris founded?

    Vitaeris was founded in 2016
  2. Who is Vitaeris's CEO?

    Vitaeris's CEO is Kevin Chow
  3. How much revenue does Vitaeris generate?

    Vitaeris generates $3M in revenue
  4. How much funding does Vitaeris have?

    Vitaeris has historically raised $7M in funding
  1. Where is Vitaeris's headquarters?

    Vitaeris's headquarters is in Vancouver British Columbia, CA
  2. How many employees does Vitaeris have?

    Vitaeris has 15 employees
  3. What sector does Vitaeris operate in?

    Vitaeris is in Pharmaceuticals
  4. Who are Vitaeris's competitors?

    Vitaeris's top competitors are Aurinia, Eupraxia Pharmaceuticals, WEX Pharmaceuticals, Inc.